Neteera Technologies vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Israeli healthtech with FDA-cleared and CE-certified contactless RPM system that captures vital signs without sensors touching the patient; $6.7M Series B; 11–50 employees; active clinical deployments.
About
Neteera Technologies is an Israeli digital health company developing contactless remote patient monitoring (RPM) solutions that capture vital signs and behavioral parameters without any physical contact with the patient. Founded and headquartered in Israel, Neteera's technology uses proprietary radar-based sensing to measure respiration rate, heart rate, body movement, and other physiological signals through a bedside device — no wearables, electrodes, or patient cooperation required. This contactless approach is particularly valuable for patients who cannot tolerate wearable sensors (elderly, agitated, or critically ill patients) and for settings requiring continuous monitoring without nursing staff intervention.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.